Chinese API Imports Eclipse Indian Plants
This article was originally published in PharmAsia News
Executive Summary
Indian firms have underscored growing concern around an ''over-dependence'' on Chinese active pharmaceutical ingredient (API) imports and the potentially crippling effect these could have on India's own essential drug supplies, should there be any turbulence in Indo-China relations.